TITLE:
      Behavior and Naltrexone Treatment for Alcoholics
SUMMARY:
      The study's purpose is to improve alcoholism treatment by investigating the combined
      effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment -
      CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of
      CSTCET or a control treatment as inpatients followed by 12 consecutive weeks of receiving
      either naltrexone or placebo as outpatients. Followups at 24, 48, and 72 weeks after
      treatment is completed.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Meets criteria for alcohol dependence.

        Exclusion Criteria:

          -  Current diagnosis of dependence on other substances except nicotine.

          -  A history of psychosis or current psychotic symptoms.

          -  Current suicidality, homocidality, or psychiatric symptoms that require additional
             medication.

          -  Current use of disulfiram (Antabuse).

          -  Evidence of significant cerebral, renal, thyroid, or cardiac disease.

          -  History of opioid abuse in the previous year.

          -  History of cirrhosis, hepatocellular disease, or elevated bilirubin.

          -  Females who are pregnant, nursing, or not using a reliable method of birth control.
